 |
JOURNAL TOOLS |
| Publishing options |
| eTOC |
| To subscribe |
| Submit an article |
| Recommend to your librarian |
ARTICLE TOOLS |
| Publication history |
| Reprints |
| Permissions |
| Cite this article as |
| Share |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
LETTERS TO THE EDITOR
Minerva Endocrinologica 2020 September;45(3):264-5
DOI: 10.23736/S0391-1977.20.03189-2
Copyright © 2020 EDIZIONI MINERVA MEDICA
language: English
Tolvaptan efficacy and drug-drug interactions
Matteo PICCICA 1, Gregorio BASILE 1, Filippo BARTALESI 2, Gabriele PARENTI 3, Alberto FARESE 2, Lisa BUCI 3, Giampaolo CORTI 1, 2, Alessandro BARTOLONI 1, 2, Alessandro PERI 4 ✉
1 Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; 2 Unit of Infectious and Tropical Diseases, Careggi University Hospital, Florence, Italy; 3 Unit of Pituitary Diseases and Sodium Alterations, Department of Endocrinology, Careggi University Hospital, Florence, Italy; 4 Pituitary Disease and Sodium Alterations Unit, Department of Endocrinology, University of Florence, AOU Careggi, Florence, Italy